SJ Medical
SJ Medical
Engineered for smooth navigation and predictable clinical performance in high-pressure percutaneous procedures.
Cardiovascular diseases (CVDs) represent an escalating healthcare burden across West Africa, with Benin witnessing a steady increase in admissions related to ischemic heart disease, myocardial infarction, and atherosclerosis. Historically, public hospitals such as the Centre National Hospitalier et Universitaire Hubert Koutoukou Maga (CNHU-HKM) in Cotonou and regional private health structures have struggled with a major clinical bottleneck: the availability of high-quality, cost-efficient interventional cardiology consumables.
Developing robust clinical capacities for Percutaneous Coronary Intervention (PCI) is no longer just a luxury of high-income nations; it is a critical requirement for West African clinical networks. The transition from open-heart surgical techniques to minimally invasive cath-lab procedures significantly reduces patient recovery times, limits hospital stays, and lowers overall procedural risks. However, the consistent supply of reliable guide wires, dilatation balloons, microcatheters, and essential antiplatelet/anticoagulant drug APIs remains a structural challenge for local health institutions.
For procurement officers in major medical distribution houses in Benin, securing medical devices involves overcoming severe logistical and financial barriers. The Benin Ministry of Health (Ministère de la Santé du Bénin) has prioritized the upgrade of Cotonou's medical platforms, which directly spurs demand for CE-certified medical implants and accessories. Distributors must balance cost constraints with stringent safety standards to ensure that clinical teams have uninterrupted access to PTCA kits during emergencies.
By bypassing multiple layers of European distribution intermediates, Benin medical institutions can partner directly with original device manufacturers (OEMs). This direct sourcing model slashes unit costs by 30% to 50%, enabling universal access to life-saving coronary angioplasty procedures across public and private hospitals.
The core of modern medical device manufacturing rests upon precision engineering and cleanroom integrity. As a dedicated manufacturer, Hangzhou SJ Medical Co., Ltd. implements a state-of-the-art manufacturing facility spanning 5,000 square meters, fully integrated with China's advanced Industry 4.0 medical hardware systems. Our facility contains a high-specification cleanroom environment, including localized Class 100 sterile environments specifically designed for assembling delicate interventional devices like PTCA guide wires and dilatation balloons.
Our digital supply chain integration ensures real-time quality logging and traceability for every batch exported to Benin. From raw chemical synthesis of antiplatelet agents like Ticagrelor to the extrusion of multi-lumen catheters, our vertical integration mitigates the global supply chain bottlenecks that frequently impact hospitals in landlocked or developing markets.
Developing interventional programs in Cotonou and Porto-Novo requires medical equipment tailored to the unique clinical environment of West Africa. For example, radial access is increasingly favored over femoral access in emerging clinics because it reduces post-operative bleeding risks and allows for same-day discharge—vital where inpatient beds are limited. This transition requires radial-friendly guiding catheters with pre-shaped curves (e.g., Judkins Left/Right, Amplatz) that provide robust backup support.
In acute myocardial infarction settings, time-to-balloon inflation determines patient survival. The availability of reliable Balloon Expansion Pressure Pumps and highly pushable PTCA Dilatation Balloon Catheters ensures that local emergency rooms can restore coronary perfusion rapidly. High performance under pressure is vital: the balloon must cross narrow lesions smoothly without damaging the vessel wall, requiring high crossability, trackability, and pushability.
Post-PCI success depends heavily on pharmacological therapy to prevent stent thrombosis. Raw APIs like Ticagrelor and Bivalirudin are crucial imports for local pharmaceutical compounding labs and distribution hubs in Benin. Supplying high-purity raw active pharmaceutical ingredients enables cost-effective domestic production of essential antiplatelet and anticoagulant medications, making long-term therapy affordable for local patients.
Full portfolio of access tools, inflation accessories, and cardiovascular drug APIs designed for clinical reliability.
Established in 2015, Hangzhou SJ Medical Co., Ltd. is a dedicated developer, manufacturer, and commercial distributor of advanced vascular interventional medical devices. Focusing on both cardiovascular and peripheral intervention fields, we provide safe, reliable, and clinically proven medical devices to healthcare networks worldwide. Over the years, we have built a broad product catalog covering key access systems, diagnostic and dilatation catheters, support accessories, and active pharmaceutical ingredients (APIs).
Our commitment to patient safety is backed by international quality management certifications, including ISO 13485, CE Mark approval, and CFDA clearance. These achievements allow us to export to strict regulatory markets across Europe, Asia, the Middle East, and Africa.
Our current international footprint includes long-term clinical distribution partnerships in Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, Egypt, and now expansion initiatives within Benin. By working with domestic healthcare networks in West Africa, we aim to establish a reliable, high-volume supply pipeline that ensures essential tools are always available at the point of care.
Our engineering team brings decades of combined experience in polymer extrusion, hydrophilic surface coating, and mechanical performance optimization. From pre-sales consulting and regulatory documentation support to custom OEM packaging, we offer end-to-end support to clinical distributors and hospital purchasing syndicates.
Important details on registration, shipping, shelf-life, and OEM options for medical procurement buyers in West Africa.
Yes. Our cardiovascular interventional consumables carry European CE Mark approval and are manufactured in compliance with ISO 13485 quality systems. We provide the necessary dossiers, Certificates of Free Sale (CFS), and batch sterilization reports to support import clearance with the Benin Ministry of Health (DPMED).
We offer sea freight (typically 35–45 days transit to the Port of Cotonou) and air cargo (typically 5–8 working days to Cotonou Cadjehoun Airport, COO). For high-value, sterile consumables like microcatheters and PTCA guide wires, we recommend temperature-regulated air cargo to prevent structural changes in packaging from extreme heat.
Our catheters are packaged in validated Tyvek pouch systems, which provide an EO-sterilized shelf-life of 2 to 3 years. We recommend storing them in cool, dry facilities (below 25°C, humidity 30%–65%) to ensure packaging integrity and optimal hydrophilic coating performance.
Yes. We supply high-purity active pharmaceutical ingredients (APIs), including Ticagrelor and Bivalirudin, to licensed pharmaceutical manufacturers and clinical research centers. Each shipment includes a detailed Certificate of Analysis (CoA) and HPLC purity profiling reports.
We offer flexible OEM and ODM services. We can configure PTCA guide wires and balloon dilatation catheters with custom stiffness, coatings, lengths, and branding to match your local market requirements.
Equip your clinics, laboratories, and distribution networks with CE-certified, high-precision interventional cardiology tools.